Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Workplace Tobacco Cessation And Oral Cancer Screening Study
This study has been completed.
Sponsors and Collaborators: Tata Memorial Hospital
Department of Atomic Energy
Information provided by: Tata Memorial Hospital
ClinicalTrials.gov Identifier: NCT00750503
  Purpose

Tata Memorial Hospital has initiated Workplace Tobacco Cessation and Oral Cancer Screening Programme in Chemical Industry at Khed, Ratnagiri. Appropriate interventions for tobacco cessation will be carried at monthly intervals for twelve months duration. The tobacco cessation rates based on history will be validated with the urinary cotinine levels.


Condition Intervention Phase
Tobacco Cessation
Oral Cancer
Behavioral: Behavioural and Pharmacotherapy for tobacco cessation
Phase III

MedlinePlus related topics: Cancer Oral Cancer
Drug Information available for: Cotinine
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Open Label, Single Group Assignment, Efficacy Study
Official Title: Workplace Tobacco Cessation And Oral Cancer Screening Study

Further study details as provided by Tata Memorial Hospital:

Primary Outcome Measures:
  • The prevalence of tobacco use and the the change in Knowledge, Attitude and Practices during post intervention. The reasons for initiation and continuation of tobacco consumption habit. The tobacco quit rates. [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The prevalence of oral precancerous and cancerous lesions among this group and its correlation with the different forms and frequency of tobacco use. [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Enrollment: 104
Study Start Date: June 2007
Study Completion Date: August 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Behavioural and Pharmacotherapy for tobacco cessation
    Professional help in the form of health awareness sessions, focus group discussion, one to one counseling and pharmacotherapy was provided to the employees by a team of doctors and counselors from Tata Memorial Hospital. Self reporting of tobacco history was validated with Rapid Urine cotinine test. Naked eye examination of oral cavity of all employees for detection of oral pre-cancers and cancers was conducted. Nursing staff and Doctors attached to the industry and from the local referral hospital were invited to participate as trainees during the active intervention sessions for local manpower development.
Detailed Description:

The prevalence of tobacco use in India among men has been reported to be high in most parts (generally exceeding 50%). It's use is more common in rural areas as compared to urban areas. Oral cancer, the main cause of which is tobacco, is common in men in developing countries and the most common cancer among men in India. The five year survival rate for oral and pharyngeal cancers even in premier institute like the Tata Memorial Hospital ranges from a poor 8% (hypo pharynx) to 43% (lower lip). Evidence has shown that cessation is the only intervention with the potential to reduce tobacco related mortality in the short- term and medium- term. An emphasis on prevention of tobacco consumption will, in the short run, only have a limited positive effect on tobacco related morbidity and mortality, as prevention strategies do not affect existing consumers. Workplace tobacco cessation activities in India are still in rudimentary stage.

In the proposed study of one year duration, professional help in the form focus group discussion, one to one counseling and pharmacotherapy will be provided to the employees by a team of doctors and counsellors from Tata Memorial Hospital. Self reporting of tobacco history will be validated with Biochemical test. This will add objectivity to the programme, so that, if successful, it can be replicated as a model to promote tobacco control activities at other workplaces. Naked eye examination of oral cavity of all employees for detection of oral pre-cancers and cancers will be done by doctors from the Tata Memorial Hospital. The employees with lesions may be referred for further management, if required. Nursing staff and Doctors attached to the industry and from the local referral hospital will be invited to participate as trainees during the active intervention sessions.

The long term objective of this initiative is to establish a model workplace tobacco cessation and oral cancer screening programme. It will contribute to the human resource and infrastructure development for tobacco cessation services at the industrial unit and at the local referral hospital. Proposed tobacco cessation services in the chemical industry would be of great help for boosting Anti - Tobacco Activities not only in the particular factory unit but also in the nearby industrial and residential zone.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All 104 employees working in the chemical industrial unit at Khed, Ratnagiri, are eligible to participate.

Exclusion Criteria:

  • There are no exclusion criteria.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00750503

Locations
India, Maharashtra
Chemical Industry
Tal. Khed, District : Ratnagiri, Maharashtra, India
Sponsors and Collaborators
Tata Memorial Hospital
Department of Atomic Energy
  More Information

Responsible Party: Tata Memorial Hospital ( Dr. Gauravi Ashish Mishra, Assistant Professor and Assistant Physician )
Study ID Numbers: 458
Study First Received: September 9, 2008
Last Updated: September 9, 2008
ClinicalTrials.gov Identifier: NCT00750503  
Health Authority: India: Indian Council of Medical Research

Keywords provided by Tata Memorial Hospital:
tobacco cessation
behavioral therapy
pharmacotherapy
workplace
oral cancer screening
Tobacco Quit rates

Study placed in the following topic categories:
Mouth Diseases
Oral cancer
Head and Neck Neoplasms
Stomatognathic Diseases
Lip and oral cavity cancer
Lip Neoplasms
Mouth Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Lip Diseases

ClinicalTrials.gov processed this record on January 16, 2009